Background: Post-operative atrial fibrillation (POAF) frequently occurs after cardiac
Introduction
Atrial fibrillation (AF) is the most common cardiac arrhythmia. Post-operative AF (POAF) frequently occurs after cardiac surgery and can induce thromboembolic events and heart failure, prolong the hospital stay, and increase the total medical cost, leading to a poor prognosis. [1] The incidence of POAF is as high as 20-30%, even with the use of beta-blockers, which are the only recommended prophylactic medication for POAF. [2, 3] Furthermore, the mechanisms of POAF have not been fully elucidated.
Recent studies suggest that a reduced utilization of fatty acids in the heart contributes to the progression of left ventricular (LV) hypertrophy, LV remodeling, and chronic heart failure. [4, 5] In addition, various types of arrhythmia, including atrial tachycardia, are observed at a higher rate in children with inherited fatty acid oxidation deficiencies. [6] Therefore, POAF might be attributable to impaired fatty acid metabolism in the atrium.
Fatty acid binding protein-3 (FABP3; also known as heart FABP [H-FABP]), a small cytoplasmic protein, has been isolated from a wide range of tissues, including heart and skeletal muscles. FABP3 is involved in the uptake of fatty acids and their subsequent transport towards the mitochondrial β-oxidation system. [7] The aim of the present study was to determine whether gene expression related to cardiac fatty acid metabolism, including fatty acid transport, is changed in the atrium of patients with POAF.
Materials and Methods

Subjects
A prospective short-term, observational study was conducted at a single center. A total of 52 consecutive patients who underwent cardiovascular surgery between 2013 and 2015 were potentially eligible for the study. The exclusion criteria included emergent surgery, a lack of myocardial specimen availability due to severe scar formation, and a clinical history of chronic or paroxysmal AF. After applying the exclusion criteria, 38 patients remained. The university ethics committee approved the research protocol (No, 012-0141) and written informed consent was obtained from each patient. The study was registered in the UMIN Clinical Trials Registry: UMIN000012405.
Post-operative AF
POAF has been reported to occur within 2-4 days after cardiac surgery, with a peak incidence of ~70% by the end of the fourth post-operative day and in >80% the arrhythmia terminates by the end of the fifth post-operative day. [8, 9] Various definitions of POAF duration (from 30 seconds to 30 minutes) have been reported. [10] [11] [12] In the present study, POAF was defined as AF lasting at least 5 minutes within 7 days after the surgery. The electrocardiogram was monitored for 24 hours a day using a telemetry system (FUKUDA DENSHI, Tokyo, Japan). The therapeutic strategy for POAF involved anticoagulation, normalization of serum potassium, and infusion of class I antiarrhythmic agents. Cardioversion was performed when hemodynamic compromise was evident. Amiodarone was used for refractory POAF.
Pre-operative echocardiography
A Vivid Seven system (GE/Vingmed, Milwaukee, WI, USA) with an M3S (2.5-3.5 MHz) transducer, Aplio system (Toshiba Medical Systems, Tokyo, Japan) with a 2.5
MHz transducer, or a Philips system (Philips Ultrasound, Bothell, WA, USA) with a 2.5
MHz transducer was used for pre-operative echocardiography. Left ventricular end-diastolic/end-systolic dimensions and the left atrial diameter were measured from the parasternal long axis view. Left ventricular ejection fraction was measured using the modified Simpson method. The mitral regurgitation grade was determined using the regurgitation jet area-to-left atrium ratio (1: mild, <20%; 2: moderate, 20%-40%; 3:
severe, >40%). The tricuspid regurgitation grade was determined using the regurgitation jet area (1: mild, <5 cm 2 ; 2: moderate, 5-10 cm 2 ; 3: severe, >10 cm 2 ). Aortic valve stenosis was defined using the valve area (1: mild, >1.5 cm 2 ; 2: moderate, 1.0-1.5 cm 2 ;
3: severe, <1.0 cm 2 ). Aortic valve regurgitation was determined using a combination of jet width/outflow tract, pressure half time, and diastolic reverse flow at the abdominal aorta (1: mild; 2: moderate; 3: severe). [13] The E and A waves of the transmitral flow (E/A) were measured using pulse Doppler. Deceleration time was measured as the time interval from the maximum E wave point to baseline levels.
Atrial electromechanical delay was determined using tissue Doppler as the time interval from the onset of the P-wave on the electrocardiogram to the beginning of the A' wave at the lateral and medial mitral annulus. [14] Intra-left atrial electromechanical delay was then calculated as the difference between the lateral and medial electromechanical delay. [15] Blood glucose, insulin, and free fatty acid levels
Within two days before surgery, blood was collected in the early morning after 10 hours of fasting in all patients. Blood glucose, insulin, and free fatty acid levels were measured using enzymatic and colorimetric methods. Just after the blood collection, an oral glucose tolerance test (OGTT, 75 g) was performed in the non-diabetic patients (n=32/38; one non-diabetic patient could not tolerate glucose intake). The glucose tolerance types were defined according to the guidelines of the Japan Diabetes Society (2012) using the blood glucose level at 120 minutes after OGTT ingestion as follows:
normal, blood glucose <139 mg/dl; impaired, blood glucose 140-199 mg/dl; diabetic, blood glucose >200 mg/dl. Homeostasis Model Assessment (HOMA) R and β (parameters of insulin resistance and secretion, respectively) were calculated as follows:
HOMA-R = (fasting insulin, μU/ml) x (fasting glucose, mg/dl) / 405; HOMA-β = 360 x (fasting insulin, μU/ml) / [(fasting glucose, mg/dl) -63].
Myocardium biopsy, surgical procedures, and myocardial protection
Before the establishment of cardiopulmonary bypass, right atrial myocardial tissue (10 x 10 mm) was excised from the insertion point of a two-staged drainage cannula. The tissue was frozen and stored at -80°C until analysis. Aortic valve replacement was performed in 27/38 patients (71%), aortic root replacement in 5/38 (13%), total arch replacement in 6/38 (16%), and concomitant coronary artery bypass grafting in 5/38 (13%). All procedures were conducted under cardiac arrest using both antegrade (15 ml/kg) and retrograde (7.5 ml/kg) cardioplegia (15°C) with a 1:1 mixture of blood and Myotector ○ R (Mochida. Pharmaceutical Co., Ltd., Tokyo, Japan). Cardioplegia was introduced every 30 minutes thereafter. The amount of antegrade solution was reduced to 7.5 ml/kg starting at the second infusion. A terminal warm antegrade cardioplegia was conducted just before de-clamping of the aorta.
Analysis of gene expression related to cardiac energy metabolism in the atrium
Quantitative 
Statistical analysis
Data are reported as means ± SD. Group differences were evaluated using Student's t-tests for continuous variables and chi-square tests for categorical variables. A multivariate logistic-regression analysis was conducted using the parameters reaching statistical significance in the univariate analyses. All reported P values are two-sided; those under 0.05 were considered to be statistically significant. Data were analysed using SPSS version 17.0 software (SPSS Inc. Chicago, IL, USA). Table 1 shows the pre-operative characteristics for the POAF and non-POAF groups.
Results
Patient characteristics
POAF was observed in 18/38 (47%) patients within 7 days after surgery. POAF recurrence was also observed in 7/18 (39%) patients after 7days of post-operative period during the hospital stay, but all the 18 POAF patients discharged home with sinus rhythm. The patients in the POAF group were significantly older compared to those in the non-POAF group. The use of beta blockers and statins was not different between the groups. Diabetes mellitus (under medication therapy) tended to be more frequent in the POAF group compared to that in the non-POAF group, without statistical significance (P=0.17). Table 2 shows the surgical procedural characteristics in the POAF and non-POAF groups. Concomitant CABG was more frequent in the POAF group. POAF and non-POAF groups also did not differ in cardiopulmonary bypass or aortic cross clamp times. Table 3 shows the pre-operative echocardiographic parameters in the POAF and non-POAF groups. Only the diameter of the left atrium was significantly larger in the POAF group compared to that in the non-POAF group. The electromechanical delay parameters were comparable between the groups.
Echocardiographic parameters
Blood glucose, insulin, and free fatty acid levels Table 4 shows the pre-operative blood glucose, insulin, and free fatty acid levels in the POAF and non-POAF groups. The fasting glucose level tended to be higher in the POAF group compared to that in the non-POAF group, without statistical significance (P=0.10). Serum free fatty acid levels were comparable between the groups. In addition, the insulin resistance parameters were not different between the groups.
Gene expression analysis of the atrial myocardium Table 5 shows the results of the multivariate analysis of pre-operative parameters for the prediction of POAF. Reduced FABP3 expression was a predictor of POAF, independent of age and left atrial diameter.
Enzymatic activities related to mitochondrial fatty acid β-oxidation and TCA cycle in the atrium
The analysis of enzymatic activity was performed in only 19/38 patients due to a shortage in myocardial tissue. However, the pre-operative characteristics of these 19
patients were comparable to those of the whole cohort (i.e., only age and FABP3 expression significantly differed between the POAF (n=10) and non-POAF (n=9) patients in this subsample). β-HAD activity was comparable between the groups (108 ± 44 vs. 92 ± 32 nM/min/mg protein, respectively, P=0.38). CS activity was also comparable between the groups (82 ± 47 vs. 76 ± 23 nM/min/mg protein, respectively, P=0.77).
Discussion
In the present study, atrial myocardial FABP3 expression was shown to be significantly reduced in patients with POAF, independent of age and left atrial diameter. This finding may contribute to the identification of the mechanism underlying POAF and may aid in the development of new prophylactic strategies for POAF in the future.
Possible mechanisms of POAF -previous reports
Structural and electrical remodeling are two elements proposed in the possible mechanisms of POAF. Structural remodeling includes the pre-operative atrial damage associated with heart disease (atrial dilatation and fibrosis), which leads to changes in the mechanical function [17] and conduction properties of the heart, and therefore contributes to the formation of new re-entry foci. [18] Electrical remodeling involves electrophysiological changes such as a shortening of the refractory period and calcium overload. [19] In cardiac surgery, ischemic myocardial damage due to inadequate cardio-protection, traumatic pericarditis and myocarditis, and an increase in adrenergic tone, may contribute to electrical remodeling. Structural and electrical remodeling is inevitable in cardiac surgery and is difficult to address in terms of prophylaxis for POAF.
Several biological factors including inflammation and autonomic nervous abnormalities can be potential substrates for POAF.[19] Bruins, et al. have reported that
elevation of complement-C-reactive protein complex (C4d-CRP) in the blood after the cardiac surgery was associated with onset of post-operative arrhythmia. [20] In the present study, maximum levels of serum CRP, an inflammation marker, within 7 days after the surgery were comparable between the POAF and the non-POAF groups (11 ± 4 vs. 9 ± 4 mg/dl, P=0.25). Previous randomized trials have shown that there was no preventive effect of POAF by administration of anti-inflammatory agents (non-steroidal anti-inflammatory drugs and corticosteroids) and these agents increased risk of infection. [21, 22] However, we could not eliminate the potential role of local inflammation in the atrium in the onset of POAF. In addition, Dimmer, et al. have
analyzed heart rate variability after CABG using the standard deviation of all RR intervals recorded by Holter ECG. They concluded that autonomic imbalance characterized by a moderate increase in the sympathetic activity preceded POAF. [23] The underlying mechanism of sympathetic activation and POAF may be calcium overload that induces triggered activity (after-depolarization) in the heart. [24] We propose that "metabolic remodeling" should be considered as a third element in POAF. Thus far, few reports exist regarding cardiac energy metabolism in POAF. [10] In a large prospective cohort study of 4,175 cases aged over 65 years, higher plasma free fatty acid was determined to be a risk factor for AF, independent of age, sex, race, hypertension, and diabetes mellitus. [25] The authors suggested a potential mechanism involving the production of lysophospholipids via a breakdown of membrane lipids and acylcarnitine from circulating free fatty acid. Furthermore, free fatty acid may inhibit the Na + / K + /ATPase pump with a subsequent increase in intracellular sodium and calcium, inducing arrhythmias. In another prospective cohort study of 15,792 participants, diabetes and HbA1c levels were reported to be associated with an increased risk of AF. [26] The authors suggested that an increased risk of LV hypertrophy due to insulin resistance results in a predisposion to AF. Although POAF was not the end-point in these two studies, these studies demonstrate that cardiac metabolic remodeling is an important player in AF.
Interpretation of decreased atrial FABP3 expression in POAF patients
Fatty acids are the major substrates for energy production (70%) in the working adult heart under normal physiological conditions. The fatty acid metabolic pathway consists of several events, including fatty acid uptake into the cytosol, transport of fatty acids from the cytosol into the mitochondria, fatty acid uptake into the mitochondria, and fatty acid β-oxidation in the mitochondria. As a lipid chaperone, the cytosolic FABP3
protein is involved in fatty acid transport towards the mitochondrial β-oxidation system and is therefore essential for fatty acid oxidation in the cells. [7] Since CD 36 and CPT-1β expression (involved in the uptake of fatty acids into the cytosol and mitochondria, respectively) and β-HAD activity (an enzyme involved in fatty acid β-oxidation) in the atrium were comparable between the groups, the reduced FABP3 expression in the POAF group may directly result in abnormal fatty acid metabolism in the atrium via the limited utilization of fatty acids in the mitochondria.
FABP3 has also a crucial role in lipotoxicity, eliminating toxic free fatty acids and their intermediates (ceramides, diacylglycerols, and long-chain acyl-CoAs) in the cytosol by transporting them to the sites of metabolic conversion. [27] Inhibition of this vital transport pathway in the heart has been reported to be associated with cardiomyopathy after cyclophosphamide and doxorubicin therapy. [28, 29] Although we did not measure the cytosolic content of fatty acid intermediates in the atrium, the decreased FABP3 expression in the atrium of patients with POAF may be related to an accumulation of fatty acid intermediates. The preexisting lipotoxicity may exacerbate mitochondrial damage, reported to be one of the mechanisms of POAF. [30, 31] Possible cause of decreased atrial FABP3 expression before cardiac surgery
Mitochondrial reactive oxygen species (ROS) release has been previously shown to be increased with an accumulation of intramyocellular lipids in the atrium of patients with type 2 diabetes. [32] Oxidative stress can lead to downregulation of FABP3 expression in the atrium. However, in the present study, parameters related to insulin resistance or type 2 diabetes were comparable between groups (except for fasting blood glucose levels, which tended to be higher in POAF patients). During the process of atrial structural remodeling consequent to various AF risk factors (such as mitral regurgitation, congestive heart failure, and hypertension), inflammation and subsequent fibrosis occur in the atrium, which leads to AF susceptibility [33] and may also decrease atrial FABP3 gene expression. Although in the present study, we did not assess fibrosis in the atrial myocardium, there was no correlation between the gene expression of FABP3 and the right atrial diameter (P=0.64). Further studies are needed to clarify the mechanism underlying the altered atrial gene expression of FABP3 in patients with POAF.
Limitations
Several limitations of the present study should be addressed. First, the number of the subjects was small. Second, the present study cannot prove a causal relationship between decreased atrial FABP3 gene expression before cardiac surgery and the increased onset of AF within 7 days after the surgery. We did not evaluate the accumulation of fatty acid intermediates in the atrium due to the limited samples. Thus, further mechanistic studies are necessary.
Conclusions
The present study demonstrated that pre-operative FABP3 gene expression in the atrium is reduced in patients with POAF, independent of age and left atrial diameter. These findings suggest a potential link between altered fatty acid transport in the atrium and increased AF onset after cardiac surgery. 
